Beam Therapeutics BEAM Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's invested capital?
- Beam Therapeutics (BEAM) reported invested capital of $1.13B in Q1 2026.
- How has Beam Therapeutics's invested capital changed year-over-year?
- Beam Therapeutics's invested capital increased by 48.3% year-over-year, from $759.7M to $1.13B.
- What is the long-term trend for Beam Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Beam Therapeutics's invested capital has grown at a 41.9% compound annual growth rate (CAGR), from $191.03M to $1.1B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).